Pro: Fresh versus frozen embryo transfer. Is frozen embryo transfer the future?

低温保存 胚胎移植 活产 怀孕 随机对照试验 玻璃化 胚胎冷冻保存 胚胎 更安全的 妊娠率 单胚胎移植 产科 医学 妇科 男科 生物 外科 计算机科学 遗传学 计算机安全 细胞生物学
作者
Christos Venetis
出处
期刊:Human Reproduction [Oxford University Press]
卷期号:37 (7): 1379-1387 被引量:13
标识
DOI:10.1093/humrep/deac126
摘要

Embryo cryopreservation has been an integral part of ART for close to 40 years and vitrification has boosted overall ART efficacy and safety. Recently, there has been a vivid scientific discussion on whether elective cryopreservation of all embryos (freeze-all) should be pursued for most patients, with a fresh embryo transfer taking place only in selected cases. In terms of efficacy, the available evidence suggests that the freeze-all strategy leads to higher live birth rates after the first embryo transfer compared to the conventional strategy in high responders, while there is no difference in normal responders. There is no evidence to suggest that the freeze-all strategy is inferior to the conventional strategy of fresh transfer when comparing cumulative live birth rates using data from all available randomized controlled trials. The incidence of ovarian hyperstimulation syndrome is significantly reduced in the freeze-all policy. However, regarding obstetric complications and neonatal outcomes, the evidence suggests that each strategy is associated with certain risks and, therefore, there is no approach that could be unequivocally accepted as safer. Similarly, limited evidence does not support the notion that patients would be universally against freeze-all owing to the inevitable delay in pregnancy achievement. Finally, the cost-effectiveness of freeze-all is likely to vary in different settings and there have been studies supporting that this policy can be, under certain conditions, cost-effective. Adoption of the freeze-all policy can also allow for more flexible treatment strategies that have the potential to increase efficacy, reduce cost and make treatment easier for patients and clinics. Importantly, freeze-all does not require the use of any experimental technologies, further training of personnel or the costly acquisition of new equipment. For these reasons, transitioning to the freeze-all policy for most patients appears to be the next logical step in ART.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
薄衫少年完成签到,获得积分10
刚刚
刚刚
大个应助冷傲新柔采纳,获得10
1秒前
11完成签到,获得积分10
1秒前
深林狼发布了新的文献求助10
1秒前
下次一定完成签到,获得积分10
2秒前
2秒前
斯文的老虎完成签到,获得积分10
2秒前
炙热的筝发布了新的文献求助10
2秒前
神勇路人发布了新的文献求助10
2秒前
3秒前
3秒前
白汐完成签到 ,获得积分10
3秒前
3秒前
逐风完成签到,获得积分10
3秒前
星辰大海应助阳光灿烂采纳,获得10
4秒前
虚幻笑晴发布了新的文献求助10
4秒前
4秒前
科目三应助乔木采纳,获得10
4秒前
万能图书馆应助yuzhu采纳,获得10
5秒前
俊逸的向珊完成签到,获得积分10
5秒前
完美世界应助牛仔采纳,获得10
5秒前
5秒前
默默幼南完成签到,获得积分10
6秒前
mly完成签到 ,获得积分10
6秒前
蜗牛发布了新的文献求助10
6秒前
现代子默完成签到,获得积分10
6秒前
田德莉娜完成签到,获得积分10
6秒前
侯长秀完成签到 ,获得积分10
6秒前
zz完成签到,获得积分10
7秒前
wintersss完成签到,获得积分10
7秒前
1616发布了新的文献求助10
7秒前
冷静的缘分完成签到,获得积分10
7秒前
子滔发布了新的文献求助10
7秒前
7秒前
机智的瑀完成签到 ,获得积分10
8秒前
8秒前
king发布了新的文献求助10
8秒前
小雨点完成签到,获得积分10
8秒前
可爱的函函应助曹俊杰采纳,获得10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 3000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
Principles of town planning : translating concepts to applications 500
Short-Wavelength Infrared Windows for Biomedical Applications 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6060287
求助须知:如何正确求助?哪些是违规求助? 7892761
关于积分的说明 16302721
捐赠科研通 5204362
什么是DOI,文献DOI怎么找? 2784323
邀请新用户注册赠送积分活动 1766998
关于科研通互助平台的介绍 1647287